Developing immune-based therapies for blood cancers

淋巴癌患者最初对治疗反应良好，但后来复发。免疫系统可以有效控制癌症。一种潜在的治疗选择是增强对癌症的自然免疫反应。这项研究调查了一种新的疫苗，激活某种免疫细胞，NKT细胞，通过提供NKT细胞激活分子来对抗淋巴瘤。结果将允许评估将基于NKT的疫苗与淋巴瘤的既定治疗方法相结合。

Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma.